Ligand Pharmaceuticals (LGND)
NASDAQ: LGND
· Real-Time Price · USD
167.06
1.09 (0.66%)
At close: Sep 11, 2025, 3:59 PM
166.70
-0.22%
Pre-market: Sep 12, 2025, 07:27 AM EDT
Material Sales, Captisol Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8.29M | -5.17M | -38.43% |
| Mar 31, 2025 | 13.46M | n/a | n/a |
| Dec 31, 2024 | n/a | n/a | n/a |
| Sep 30, 2024 | 6.25M | -1.25M | -16.60% |
| Jun 30, 2024 | 7.5M | -1.71M | -18.58% |
| Mar 31, 2024 | 9.21M | n/a | n/a |
| Dec 31, 2023 | n/a | n/a | n/a |
| Sep 30, 2023 | 3.68M | 650K | +21.47% |
| Jun 30, 2023 | 3.03M | 419K | +16.06% |
| Mar 31, 2023 | 2.61M | n/a | n/a |
| Dec 31, 2022 | n/a | n/a | n/a |
| Sep 30, 2022 | 2.1M | -218K | -9.41% |
| Jun 30, 2022 | 2.32M | 668K | +40.51% |
| Mar 31, 2022 | 1.65M | n/a | n/a |
| Dec 31, 2021 | n/a | n/a | n/a |
| Sep 30, 2021 | n/a | n/a | n/a |
| Jun 30, 2021 | n/a | n/a | n/a |
| Mar 31, 2021 | n/a | n/a | n/a |
| Dec 31, 2020 | n/a | n/a | n/a |
| Sep 30, 2020 | n/a | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |